What is William Blair's Forecast for Penumbra Q1 Earnings?

Penumbra, Inc. (NYSE:PEN - Free Report) - Research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for Penumbra in a note issued to investors on Wednesday, April 2nd. William Blair analyst M. Andrew now expects that the company will post earnings per share of $0.66 for the quarter, down from their prior forecast of $0.79. The consensus estimate for Penumbra's current full-year earnings is $3.67 per share. William Blair also issued estimates for Penumbra's Q2 2025 earnings at $0.83 EPS, Q2 2025 earnings at $0.83 EPS, Q4 2025 earnings at $1.17 EPS, Q4 2025 earnings at $1.17 EPS, Q1 2026 earnings at $0.99 EPS, Q1 2026 earnings at $0.99 EPS, Q2 2026 earnings at $1.11 EPS, Q3 2026 earnings at $1.30 EPS, Q3 2026 earnings at $1.30 EPS, Q4 2026 earnings at $1.48 EPS, FY2026 earnings at $4.88 EPS and FY2026 earnings at $4.88 EPS.

Several other equities research analysts have also recently commented on the company. Morgan Stanley raised their target price on Penumbra from $240.00 to $260.00 and gave the stock an "equal weight" rating in a research note on Wednesday, February 19th. Royal Bank of Canada boosted their target price on Penumbra from $285.00 to $313.00 and gave the company an "outperform" rating in a research report on Wednesday, February 19th. Citigroup raised their price objective on Penumbra from $220.00 to $245.00 and gave the company a "neutral" rating in a research note on Wednesday, December 11th. Bank of America initiated coverage on Penumbra in a report on Friday, March 14th. They issued a "buy" rating and a $320.00 target price on the stock. Finally, Truist Financial boosted their price target on shares of Penumbra from $285.00 to $325.00 and gave the company a "buy" rating in a research note on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $294.47.

Penumbra Trading Up 5.7 %

Penumbra stock traded up $14.59 during trading hours on Friday, reaching $270.41. 214,759 shares of the company's stock were exchanged, compared to its average volume of 406,891. The firm's 50 day simple moving average is $273.74 and its 200 day simple moving average is $246.90. Penumbra has a twelve month low of $148.00 and a twelve month high of $310.00. The company has a quick ratio of 3.25, a current ratio of 6.01 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $10.42 billion, a PE ratio of 790.19, a PEG ratio of 2.83 and a beta of 0.56.

Penumbra (NYSE:PEN - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.88 by $0.09. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. The firm had revenue of $315.52 million for the quarter, compared to the consensus estimate of $311.63 million.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC boosted its position in Penumbra by 42,409.9% during the first quarter. GAMMA Investing LLC now owns 189,594 shares of the company's stock worth $50,699,000 after purchasing an additional 189,148 shares during the period. Versant Capital Management Inc boosted its holdings in Penumbra by 893.5% in the 1st quarter. Versant Capital Management Inc now owns 308 shares of the company's stock worth $82,000 after buying an additional 277 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in Penumbra by 74.7% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,115 shares of the company's stock valued at $740,000 after buying an additional 1,332 shares in the last quarter. Employees Retirement System of Texas raised its holdings in Penumbra by 31.9% during the 4th quarter. Employees Retirement System of Texas now owns 5,273 shares of the company's stock valued at $1,252,000 after acquiring an additional 1,274 shares during the period. Finally, Jefferies Financial Group Inc. purchased a new stake in shares of Penumbra during the fourth quarter worth $760,000. Institutional investors own 88.88% of the company's stock.

Insider Transactions at Penumbra

In other Penumbra news, Director Thomas Wilder sold 360 shares of Penumbra stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $266.93, for a total value of $96,094.80. Following the sale, the director now owns 4,692 shares of the company's stock, valued at approximately $1,252,435.56. The trade was a 7.13 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Adam Elsesser sold 16,565 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $272.24, for a total transaction of $4,509,655.60. Following the transaction, the chief executive officer now directly owns 52,495 shares of the company's stock, valued at $14,291,238.80. This represents a 23.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 111,236 shares of company stock worth $31,222,390 in the last ninety days. Company insiders own 5.00% of the company's stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.